Global technology giant Microsoft announces that it has partnered with actionable artificial intelligence services and solutions providing company Synaptiq to launch a new machine vision tool to reduce infections in hospitals.
The collaboration aims at addressing a challenging medical issue of infections caused by central lines inserted into the body to deliver chemotherapy or other drugs.
Microsoft identified central line infections as a major issue, which led to the commencement of this new project of developing solutions for the problem. It has been a long-standing problem in the United States as infections cause countless deaths every year.
Read More: AI and Robotics Technology Park launched in IISc Bengaluru
The prime reason for the spread of such infections is inefficient and improper care of lines, allowing pathogens to enter the body.
Therefore the newly launched novel machine vision tool will considerably help reduce those numbers. The competent tool uses cell phone photographs to analyze and evaluate the condition line dressings to help identify risks.
The machine vision tool sends an alert to designated users when it identifies an issue in the lines using Microsoft Teams application, enabling workers to quickly fix it to minimize the chances of infection spreading.
Additionally, the tool also uses Microsoft Power BI for its dashboards collating the data. Synaptiq is now looking for healthcare partners for the pilot to train and evaluate the tool, which could be used in hospitals in the future.
United States-based actionable AI firm Synaptiq was founded by Sklarew and Tim Oates in 2015. The company specializes in building AI-powered apps in partnership with its customers.
Sklarew said, “We especially look for clients and partners that are interested in more strategic relationships where we have an opportunity to co-develop, co-market, and/or co-sell solutions or products. This includes creating spin-offs to bring new, leading-edge innovations to market, faster, as new products.”
